
|Articles|November 30, 2022
CMSC Best Practices in Multiple Sclerosis Therapies Roundtable
An expert-led panel discuss the best practices and different treatment considerations in multiple sclerosis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Clears Roche's Single-Biomarker Elecsys pTau217 Blood Test for Alzheimer Disease
2
Factor XIa Inhibition as a Potential New Frontier in Secondary Stroke Prevention: Seemant Chaturvedi, MD
3
FDA Clears PrecivityAD2 Alzheimer Blood Test for Symptomatic Patients 40 and Older
4
FDA Accepts Ecopipam NDA for Tourette Syndrome, Remlifanserin Receives Fast Track Designation for AD Psychosis, Alterity Reaches FDA Alignment on ATH434
5
















